
pmid: 22108283
Prolactin-secreting pituitary tumors are a common cause of amenorrhea and infertility in premenopausal women. The goals of therapy are to normalize prolactin, restore gonadal function and fertility, and reduce tumor size, and dopamine agonists are the preferred therapy. Clinically significant tumor enlargement during pregnancy is uncommon and dependent on tumor size and prepregnancy treatment.
Fetal Development, Hyperprolactinemia, Pregnancy Complications, Pregnancy, Dopamine Agonists, Humans, Female, Pituitary Neoplasms, Prolactinoma, Infertility, Female, Pregnancy Complications, Neoplastic
Fetal Development, Hyperprolactinemia, Pregnancy Complications, Pregnancy, Dopamine Agonists, Humans, Female, Pituitary Neoplasms, Prolactinoma, Infertility, Female, Pregnancy Complications, Neoplastic
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 32 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
